Exelixis
EXEL
#1294
Rank
S$22.37 B
Marketcap
S$91.72
Share price
3.12%
Change (1 day)
70.03%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company